← Open Payments lookup

BEAU MUHLBACH: Open Payments

NPI 1841792710 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$200 in 10 payments from 6 companies in 2025. Trend: 2023 $44 · 2024 $38 · 2025 $200

Food & beverage: $200
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.3$68
Merck Sharp & Dohme LLC2$37
Amgen Inc.2$30
PFIZER INC.1$26
Novartis Pharmaceuticals Corporation1$26
Esperion Therapeutics, Inc.1$14

Products named: JARDIANCE, VERQUVO, REPATHA, ELIQUIS, LEQVIO, NEXLETOL.

Industry payments across TX — which companies pay providers there.